Targeted knockdown of HO-1 expression led to pronounced growth inhibition of pancreatic cancer cells and made tumour cells significantly more sensitive to radiotherapy and chemotherapy (Berberat et al, 2005). The gene discussed is HMOX1; the disease is neoplasm.